GSK shares fell after the U.K. drugmaker said it would stop working on an experimental treatment for chronic cough after ...

Flu symptoms wearing you down? While teas can't cure influenza, these six drinks can help soothe your throat and ease ...

During her freshman year of college in 2020, Lauren, from Columbus in Ohio, contracted Covid, but her cough persisted long after. Medical professionals believed she was experiencing lingering Covid ...

By Bhanvi Satija and Prerna Bedi July 17 (Reuters) - GSK will halt development of an experimental drug to treat refractory chronic cough after it failed to meet key goals across two late-stage trials, ...

Some medicines sold over the counter at pharmacies across UAE are treated as controlled substances, or banned outright, in ...

India, July 15 -- Rising pollution and changing lifestyles have made coughs a frequent health concern for Indian families.

GSK said it decided to halt the development of an experimental drug as a treatment for chronic cough after the medicine missed the key goal in a late-stage clinical study. The U.K. drugmaker said ...

Trevi Therapeutics grew its share prices by 9.85 percent on Friday to finish at $19.07 apiece, after management underscored ...

The British pharma company will discontinue camlipixant’s late-stage RCC programme, though it will continue the drug’s development in two forms of IBS.

Actor Sam Neill's death from pneumonia has renewed attention on this lung infection. Early symptoms often resemble a cold or flu, making them easily dismissed. Older adults and those with underlying ...

GSK plc provides an update on the CALM-1 and CALM-2 phase III clinical trials, which assessed the efficacy and safety of two doses of camlipixant (a P2X3 receptor antagonist) in adults with refractory ...